Clinical outcome | Control (n = 208) | Intervention (n = 234) | P-value | Hazard ratio | 95%CI | ||
---|---|---|---|---|---|---|---|
No. of events | Person-years | No. of events | Person-years | ||||
All-cause mortality | 4 | 387.8 | 5 | 449.6 | 0.92 | 1.07 | 0.29–3.90 |
CV eventsb | 4 | 384.0 | 2 | 448.6 | 0.33 | 0.43 | 0.08–2.34 |
ESRDc | 14 | 370.5 | 8 | 439.6 | 0.11 | 0.49 | 0.21–1.16 |
50% increase in serum Cr from baseline | 31 | 359.5 | 23 | 426.8 | 0.10 | 0.64 | 0.37–1.09 |
Composite clinical endpointsd | 41 | 344.3 | 29 | 417.6 | 0.03 | 0.59 | 0.37–0.96 |